I may create a new position here. OWCP could definitely hit

New Post Public Reply Private Reply Replies (1) Message Board
joey68
400
I may create a new position here. OWCP could definitely hit $10 in a few years.

OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links

OWCP Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Buffett Steps Down, New Faces at Berkshire Hathaway

Updated Category News Views 4

End of an Era: Warren Buffett's Retirement Warren Buffett—there's a name that's echoed through the halls of investment for decades. Today, he's pulling down the curtain as Chairman of Berkshire Hathaway (NYSE: BRK). No fanfare, just a nod to the inevitable with his classic, humor-tinged confession: 'Father Time always wins.' Can’t argue with the man who’s seen the...

Continue Reading
ETERC's Ele Aims to Revolutionize STEM Education for All

Updated Category News Views 6

The AI Mentor Battleground in Education Ever found yourself wondering how public schools could step up their game without dumping money down the tech rabbit hole? ETERC’s latest push with Ele may just be a game-changer for them. We're not talking about your run-of-the-mill chatbot regurgitating facts from the internet—this is an AI tricked out for personalized...

Continue Reading
GenAI Boosts Grades and Tech Savvy for Online Learners

Updated Category News Views 2

What's Really Driving GenAI Use in Online Education? Let's not beat around the bush—most folks think students turn to this newfangled generative AI mainly to smooth over academic hurdles or save time. But guess what? The University of Phoenix has gone and poked some holes in that assumption. Study Highlights Key Insights This solid piece of research from the...

Continue Reading
Calavera NY Website Revamp: Gemstone Expansion Hits

Updated Category News Views 5

Calavera New York's Bold Online Makeover When a jewelry brand that's all about slashing retail markups makes a move this big, it's worth a real close-up look. Calavera New York, a name buzzing in the diamond and gemstone scene, just dropped a redesigned website that’s turning more than a few heads. They’re known for cutting out the middleman, a strategy that already...

Continue Reading
Debt Crisis Looms: Social Security at Risk

Updated Category News Views 4

Debt Reality: A National Concern with Global Implications When it comes to the U.S. federal debt situation, the latest report from the National Seniors Policy Center is lighting a fire like no other, warning us that we're not crying wolf here. We've got fiscal numbers that may not sit well at breakfast. With roughly 67 cents of every new buck Uncle Sam borrows going to...

Continue Reading
Menopause Policy Advocacy Takes Center Stage in DC

Updated Category News Views 5

Unlikely Spotlight on Menopause at Capitol Hill If you told me a couple of years back that menopause would become a front-page political issue, I would've laughed. Yet, here we are, with over 125 advocates from 29 states converging on Washington, D.C., demanding legislative action on menopause. Why Menopause Matters in Policy The fact that more than half the population is...

Continue Reading
Sierra Ridge Advisors Join Gateway Financial Milestone

Updated Category News Views 5

Big Moves in the Financial Advisory World Let's dive right in. Here's a real shakeup in the advisory realm: 28 financial advisors and team members from Sierra Ridge Advisor Group are packing their bags for Gateway Financial Partners. We're talking about a significant shift involving $825 million in assets under advisement. Instead of sticking with Sierra Ridge as it...

Continue Reading
Heafner Takes Helm at HGTC Amid Strategic Shifts

Updated Category News Views 1

A New Era for HGTC with Dr. Heafner at the Wheel Out of the frying pan and into the fire—Dr. Lori Heafner is stepping up to lead Horry-Georgetown Technical College (HGTC) with a clean slate and a hefty load of responsibility come January 2027. After enduring an intense national search by the Area Commission, she beat out tough competition to earn the role. It's not just...

Continue Reading
Bascom's Strategic Play on a Dallas Apartment Deal

Updated Category News Views 8

Unpacking Bascom's Jasmine Acquisition In a market that's been more slippery than a greased pig, Bascom Group's move buying up Jasmine Apartments is capturing some eyes. Situated in North Dallas, this 370-unit complex ain't just another brick in the wall—it's Bascom's 42nd entry into Texas, reinforcing their knack for sniffing out deals others might tiptoe around,...

Continue Reading
Arizona Voters Demand Clear Plans for 2026 Election

Updated Category News Views 3

A Shift in Voter Expectations: Clear Actions Needed Arizona voters have spoken, and they aren't looking for the same old political song and dance anymore. They crave something meatier—action, not just words. Heading into the 2026 general election, folks in the Grand Canyon State are demanding concrete solutions and straightforward answers from those who seek to lead...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Promising Energy Stocks for Growth in 2023

Updated Category News Views 206

Opportunity in Oversold Energy Stocks In the dynamic world of the energy sector, certain stocks are presenting unique buying opportunities as they become increasingly undervalued. This analysis aims to illuminate the potential for growth among these oversold stocks. Understanding the RSI Indicator The Relative Strength Index (RSI) is a key momentum indicator that helps...

Continue Reading
Taylor Farms and Foodiverse Unite for Salad Operations Growth

Updated Category News Views 191

Key Acquisition by Taylor Farms and Foodiverse Foodiverse will manage all activities for the unified businesses. Taylor Farms and Foodiverse have successfully acquired two production plants that specialize in ready-to-eat salads from Bonduelle's fresh sector in Germany. This acquisition allows Foodiverse to consolidate its operations and enhance its influence in the...

Continue Reading
Fast Fresh Brands Selects USIM for Innovative Media Strategy

Updated Category News Views 174

Fast Fresh Brands Selects USIM as Media Agency of Record Fast Fresh Brands (FFB), known for its health-centric quick-service restaurant concepts such as Bee Healthy Café and Nature's Table, has appointed USIM as its media agency of record. This partnership aims to leverage innovative strategies that will help elevate FFB's brand visibility and reach, connecting with...

Continue Reading
Genmab Highlights Epcoritamab's Promise in Hematology Research

Updated Category News Views 48

Genmab Unveils Epcoritamab Innovations at ASH 2024 At the much-anticipated conference, the 66th Annual Meeting of the American Society of Hematology (ASH), Genmab A/S (Nasdaq: GMAB) showcased its advancements in the development of epcoritamab-bysp (known commercially as EPKINLY®). This revolutionary T-cell engaging bispecific antibody is administered subcutaneously and...

Continue Reading
TScan Therapeutics Secures Funding Surge with Warrant Sale

Updated Category News Views 83

TScan Therapeutics Secures $30 Million Funding TScan Therapeutics has successfully secured a substantial investment of $30 million through the sale of warrants. Jason A. Amello, the Chief Financial Officer of TScan, emphasized the critical role this funding will play in extending the company's financial runway. With these additional gross proceeds, TScan anticipates its...

Continue Reading